Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MOUNTAIN VALLEY MD HOLDINGS INC.

(20MP)
Verzögert Börse Stuttgart  -  12:54:28 31.01.2023
0.0414 EUR   +13.11%
12.01.Mountain Valley Md Holdings Inc. gibt den Wechsel von Azhar Rana, Chief Medical Officer, in eine beratende Funktion bekannt
CI
2022Mountain Valley MD Holdings Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. September 2022
CI
2022Mountain Valley MD Holdings Inc. beginnt mit dem kommerziellen Verkauf von Agrarius, einer Agro-Pflanzen-Technologie
CI
ÜbersichtKurseChartsNewsTermineUnternehmenFinanzenDerivateFonds 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über MOUNTAIN VALLEY MD HOLDINGS INC.
12.01.Mountain Valley MD Says Chief Medical Officer Transitioning to Advisory Role; Shares Do..
12.01.Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role
12.01.Mountain Valley Md Holdings Inc. Announces Transition of Azhar Rana, Chief Medical Offi..
2022Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting S..
2022Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting S..
2022Mountain Valley MD Provides Business Update, Focus On Commercialization Phase
2022Mountain Valley MD Provides Business Update, Focus On Commercialization Phase
2022Mountain Valley MD Holdings Inc. Reports Earnings Results for the Second Quarter and Si..
2022Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology
2022Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology
2022Mountain Valley MD Holdings Inc. Commences Commercial Sales of Agrarius, an Agro Plant ..
2022Mountain Valley Md : Q1 Management Discussion and Analysis
2022Mountain Valley Md : Q1 Financial Statements
2022Mountain Valley MD Holdings Inc. Reports Earnings Results for the First Quarter Ended J..
2022Mountain Valley MD Holdings Inc. Reports Earnings Results for the Full Year Ended March..
2022Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluve..
2022Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluve..
2022Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study for Soluve..
2022Mountain Valley MD Holdings Provides Business Update
2022Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support K..
2022Mountain Valley MD Holdings Inc. Appoints Elizabeth Norton to Advisory Role
2022Mountain Valley MD Holdings Inc. Reports Earnings Results for the Third Quarter and Nin..
2022Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock O..
2021Mountain Valley MD Holdings Inc. Reports Earnings Results for the Second Quarter and Si..
2021Mountain Valley MD Holdings Completes Licensing Agreement With Red White and Bloom Bran..
2021Mountain Valley MD Holdings Completes Licensing Agreement with Red White and Bloom Bran..
2021Mountain Valley Md : Provides Business Update, Results of Shareholder Meeting
2021Mountain Valley Md : Announces Letter of Intent with Red White and Bloom Brands Inc.
2021Mountain Valley MD Holdings Announces Letter of Intent with Red White and Bloom Brands ..
2021Mountain Valley MD : Announces Voluntary Retraction of Reported Data ..
2021Mountain Valley Md Holdings Inc. Announces Voluntary Retraction of Report Data Set
2021Mountain Valley Md : Announces Annual Shareholder Meeting
2021Mountain Valley Md : to Graduate to OTCQX Best Market, Updates Broader Up-Listing Strategy
2021Mountain Valley Md : Appoints Chief Medical Officer
2021Mountain Valley MD Holdings Inc. Appoints Azhar Rana as Chief Medical Officer
2021Mountain Valley Md Holdings Inc. Reports Earnings Results for the Full Year Ended March..
2021Mountain Valley Md : Announces Appointment of Advisors, Stock Option Grant and Provides Up..
2021Mountain Valley MD Holdings Inc. Announces Appointment of Advisors
2021Mountain Valley MD Holdings Inc. Announces Results From Cold Chain Storage Evaluation o..
2021Mountain Valley Md Provides Update O : Patent Award, FDA Collaborative Research Agreement,..
2021Mountain Valley Md : to Host Live, Virtual Town Hall Q&A Session with Company President & ..
2021Mountain Valley MD Holdings Inc. Receives Successful Results from BSL-4 COVID-19 Cleara..
2021Mountain Valley Md : Provides Update on Current Trials
2021Mountain Valley MD Holdings Inc. Provides Update on Current Trials
2021Mountain Valley MD Files Patent and Begins Pre-Clinical Trials to Enter $100 Billion Ca..
2021Mountain Valley Md : Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Pate..
2021Mountain Valley MD Holdings Inc. Files a Novel Cancer Adjuvant Patent and is Proceeding..
2021Mountain Valley Md Holdings Inc : . Proceeding with Application to List on the TSX Venture..
2021Mountain Valley Md : Commencing trials in bangladesh striking pharmaceutical production ag..
2021Mountain Valley Md : IIROC Trade Resumption - MVMD
2021Mountain Valley Md : Commencing Trials in Bangladesh, Striking Pharmaceutical Production A..
2021Mountain Valley Md : IIROC Trading Halt - MVMD
2021Mountain Valley Md : Achieves solubilization of selamectin files trademark for selactosol
2021Mountain Valley Md : Achieves Solubilization of Selamectin, Files Trademark For Selactosol..
2021Mountain Valley MD Holdings Inc. Announces It Has Achieved A Water Solubilized Selamect..
2021Mountain Valley Md : Proceeding with FDA 505(b)(2) Pathway Application for Novel Ivectosol..
2021Mountain Valley MD Holdings Inc. Formulates Its Ivectosol Product and Provides Trial Qu..
2021Mountain Valley MD Holdings Inc. Proceeding with FDA 505(B)(2) Pathway Application for ..
2021Mountain Valley Md : Commencing Husbandry Animal Trials, Appoints Seasoned Doctor of Veter..
2021Mountain Valley Md Commencing Husbandry Animal Trials, Appoints Seasoned Doctor of Vete..
2021Mountain Valley MD Holdings Inc. Commences Husbandry Animal Trials with Third-Party Pre..
2021Mountain Valley MD Holdings Inc. Appoints Michel Rondeau to Advisory Board
2021Mountain Valley Md : Confirms Quicksome™ License Agreement, first RevenueS
2021Mountain Valley MD Confirms Quicksome™ License Agreement
2021Mountain Valley Md : IIROC Trade Resumption - MVMD
2021Mountain Valley Md : IIROC Trading Halt - MVMD
2021Mountain Valley Md : to Include Testing of South African Mutation in Upcoming COVID-19 BSL..
2021Mountain Valley MD Holdings Inc. to Include Testing of South African Mutation in Upcomi..
2021Mountain Valley Md : Announces Stock Option Grant and Warrant Exercise Update
2021Mountain Valley MD Holdings Inc. will Change its Ticker to MVMDF from MVMD
2021Mountain Valley Md : Contracts Tulane University for Adjuvant IPV Study
2021Mountain Valley MD Holdings Inc Contracts Tulane University for Adjuvant IPV Study
2021Mountain Valley Md : IIROC Trade Resumption - MVMD
2021Mountain Valley Md : Proceeding With COVID-19 Clearance Trial in Level 4 Biohazard Facilit..
2021Mountain Valley MD Proceeding With COVID-19 Clearance Trial in Level 4 Biohazard Facili..
2021Mountain Valley Md : IIROC Trading Halt - MVMD
2021Mountain Valley Md : Files Patent for Novel Vaccine Dose Sparing Adjuvant
2021Mountain Valley Md Files Patent for Novel Vaccine Dose Sparing Adjuvant
2021Mountain Valley Md : Awarded Canadian Patent for its Quicksome™ Technology
2021Mountain Valley MD Awards Canadian Patent for Its Quicksome Technology
2021Mountain Valley Md : Announces Application for OTCQB Listing in U.S., Provides Update on W..
2020Mountain Valley Md : Completes Strategic Sale of Subsidiary, Finalizing Quicksome™ L..
2020Circadian Wellness Corp. completed the acquisition of Mountain Valley Medicinals Inc. a..
2020Mountain Valley Md Holdings Inc. Files for Acceleration of Patent Examination for Solub..
2020Mountain Valley MD : Up 18% After Filing for Acceleration of Patent E..
2020Mountain Valley Md : Files for Acceleration of Patent Examination for Solubilized Ivermect..
2020Mountain Valley Md : Oversubscribes Strategic Private Placement Offering of Units
2020Mountain Valley MD Holdings Inc. announced that it has received CAD 4.3232 million in f..
2020Mountain Valley Md : Announces Strategic Private Placement Offering of Units, Appointment ..
2020Mountain Valley MD Holdings Announces Appointment of Advisor Board Members
2020Mountain Valley MD Holdings Inc. announced that it expects to receive CAD 3 million in ..
2020Mountain Valley Md : Confirms 800% Increase in Ivermectin Absorption with Solubilization T..
2020Mountain Valley MD Holdings Inc. Completes Its Initial Safety Pre-Clinical Validation o..
2020Mountain Valley Md : Secures Quicksome™ License Agreement And Strategic Sale Of Subs..
2020Mountain Valley MD Holdings Inc. Secures Quicksome License Agreement
2020Circadian Wellness Corp. entered into a share purchase and exchange agreement to acquir..
2020Mountain Valley Md : Files patent to protect science achievement in solubilization of iver..
2020Mountain Valley Md : Files Patent to Protect Science Achievement in Solubilization of iver..
2020Mountain Valley Md : Files Patent to Protect Science Achievement in Solubilization of Iver..
2020Mountain Valley Md : Provides successful quicksome sublingual pre-clinical trial dosing up..
Anstehende Termine für MOUNTAIN VALLEY MD HOLDINGS INC.